Provided by Tiger Trade Technology Pte. Ltd.

ZYMEWORKS INC (US)

24.18
-0.5100-2.07%
Post-market: 24.180.00000.00%16:34 EDT
Volume:429.53K
Turnover:10.43M
Market Cap:1.78B
PE:-22.39
High:24.92
Open:24.41
Low:23.88
Close:24.69
52wk High:28.49
52wk Low:9.03
Shares:73.75M
Float Shares:38.30M
Volume Ratio:0.85
T/O Rate:1.12%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.0800
EPS(LYR):-1.0800
ROE:-26.72%
ROA:-14.29%
PB:6.64
PE(LYR):-22.39

Loading ...

Zymeworks, Royalty Pharma enter $250M royalty-backed note financing

TIPRANKS
·
Mar 02

Earnings Flash (ZYME) Zymeworks Posts Q4 Revenue $2.5M, vs. FactSet Est of $19.2M

MT Newswires Live
·
Mar 02

Zymeworks reports Q4 EPS (55c) vs. (31c) last year

TIPRANKS
·
Mar 02

Earnings Flash (ZYME) Zymeworks Posts Q4 Net Loss $0.55 a Share, vs. FactSet Est of $0.46 Loss

MT Newswires Live
·
Mar 02

Canada's Zymeworks 2025 revenue rises 39%

Reuters
·
Mar 02

Zymeworks Q4 2025 EPS $(0.55) Misses $(0.42) Estimate, Sales $2.515M Miss $13.576M Estimate

Benzinga
·
Mar 02

Zymeworks and Royalty Pharma Enter Into $250 Million Royalty-Backed Note Financing

THOMSON REUTERS
·
Mar 02

Zymeworks Inc - Co to Retain 70% of Ziihera Royalties

THOMSON REUTERS
·
Mar 02

Zymeworks Secures $250 Million Royalty-Backed Note Financing From Royalty Pharma

Reuters
·
Mar 02

Zymeworks FY 2025 revenue rises 39% to USD 106.0 million

Reuters
·
Mar 02

Zymeworks Q4 Basic EPS USD -0.55

THOMSON REUTERS
·
Mar 02

Zymeworks Inc expected to post a loss of 42 cents a share - Earnings Preview

Reuters
·
Feb 27

Citi Reaffirms Their Buy Rating on Zymeworks (ZYME)

TIPRANKS
·
Feb 20

Zymeworks Inc. to Report Financial Results and Host Conference Call

Reuters
·
Feb 12

Zymeworks Inc. Files Initial Statement of Beneficial Ownership for SVP & Chief Medical Officer Sabeen Mekan

Reuters
·
Feb 03

Zymeworks Inc. Joins Leerink Global Healthcare Conference for Fireside Chat

Reuters
·
Jan 27

Assessing Zymeworks (ZYME) Valuation After Major Leadership And Board Reshuffle

Simply Wall St.
·
Jan 27

Zymeworks Inc. unveils strategy focused on growing royalty portfolio and advancing novel medicines for difficult-to-treat diseases

Reuters
·
Jan 21

Zymeworks Inc. Files Initial Beneficial Ownership Statement for Mark Hollywood, EVP & Chief Operating Officer

Reuters
·
Jan 14

Zymeworks Inc. Files Initial Statement of Beneficial Ownership for Director Brian N. Cherry

Reuters
·
Jan 14